These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 21080820)

  • 1. Exploiting the potential of molecular profiling in Parkinson's disease: current practice and future probabilities.
    Mellick GD; Silburn PA; Sutherland GT; Siebert GA
    Expert Rev Mol Diagn; 2010 Nov; 10(8):1035-50. PubMed ID: 21080820
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Proteomics in Parkinson's disease: current trends, translational snags and future possibilities.
    Srivastava G; Singh K; Tiwari MN; Singh MP
    Expert Rev Proteomics; 2010 Feb; 7(1):127-39. PubMed ID: 20121482
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Contribution of genomics and proteomics in understanding the role of modifying factors in Parkinson's disease.
    Singh MP; Patel S; Dikshit M; Gupta YK
    Indian J Biochem Biophys; 2006 Apr; 43(2):69-81. PubMed ID: 16955754
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Biomarkers for Parkinson's [corrected] disease: tools to assess Parkinson's disease onset and progression.
    Marek K; Jennings D; Tamagnan G; Seibyl J
    Ann Neurol; 2008 Dec; 64 Suppl 2():S111-21. PubMed ID: 19127587
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Metabolomics tools for identifying biomarkers for neuropsychiatric diseases.
    Quinones MP; Kaddurah-Daouk R
    Neurobiol Dis; 2009 Aug; 35(2):165-76. PubMed ID: 19303440
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Biomarkers for Parkinson's disease.
    Sherer TB
    Sci Transl Med; 2011 Apr; 3(79):79ps14. PubMed ID: 21508309
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Parkinson's at risk syndrome: can Parkinson's disease be predicted?
    Stern MB; Siderowf A
    Mov Disord; 2010; 25 Suppl 1():S89-93. PubMed ID: 20187248
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Biomarkers in Parkinson's disease.
    Dorsey ER; Holloway RG; Ravina BM
    Expert Rev Neurother; 2006 Jun; 6(6):823-31. PubMed ID: 16784406
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development of Parkinson's disease biomarkers.
    Prakash KM; Tan EK
    Expert Rev Neurother; 2010 Dec; 10(12):1811-25. PubMed ID: 21091313
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Diagnostic criteria and differential diagnosis of Parkinson disease].
    Takáts A
    Ideggyogy Sz; 2003 May; 56(5-6):144-54. PubMed ID: 12861955
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Biomarkers for the diagnosis and management of Parkinson's disease.
    Waragai M; Sekiyama K; Fujita M; Tokuda T; Hashimoto M
    Expert Opin Med Diagn; 2013 Jan; 7(1):71-83. PubMed ID: 23530844
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The search for biomarkers in Parkinson's disease: a critical review.
    Antoniades CA; Barker RA
    Expert Rev Neurother; 2008 Dec; 8(12):1841-52. PubMed ID: 19086880
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Proteomic profiling of cerebrospinal fluid in parkinsonian disorders.
    Constantinescu R; Andreasson U; Li S; Podust VN; Mattsson N; Anckarsäter R; Anckarsäter H; Rosengren L; Holmberg B; Blennow K; Wikkelsö C; Rüetschi U; Zetterberg H
    Parkinsonism Relat Disord; 2010 Sep; 16(8):545-9. PubMed ID: 20620095
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Exploring the relationship between essential tremor and Parkinson's disease.
    Shahed J; Jankovic J
    Parkinsonism Relat Disord; 2007 Mar; 13(2):67-76. PubMed ID: 16887374
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Olfactory dysfunction in Parkinson's disease.
    Kranick SM; Duda JE
    Neurosignals; 2008; 16(1):35-40. PubMed ID: 18097158
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Olfactory dysfunction as a diagnostic marker for Parkinson's disease.
    Haehner A; Hummel T; Reichmann H
    Expert Rev Neurother; 2009 Dec; 9(12):1773-9. PubMed ID: 19951136
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differentiating Parkinson's disease from other parkinsonian disorders.
    Alvarez MV; Evidente VG; Driver-Dunckley ED
    Semin Neurol; 2007 Sep; 27(4):356-62. PubMed ID: 17701873
    [TBL] [Abstract][Full Text] [Related]  

  • 18. How to diagnose dementia with Lewy bodies: state of the art.
    Geser F; Wenning GK; Poewe W; McKeith I
    Mov Disord; 2005 Aug; 20 Suppl 12():S11-20. PubMed ID: 16092075
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Biomarkers: Parkinson disease with dementia and dementia with Lewy bodies.
    Johansen KK; White LR; Sando SB; Aasly JO
    Parkinsonism Relat Disord; 2010 Jun; 16(5):307-15. PubMed ID: 20338799
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Biomarkers for the early detection of Parkinson's and Alzheimer's disease.
    Berg D
    Neurodegener Dis; 2008; 5(3-4):133-6. PubMed ID: 18322370
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.